Cortizone-10
Allegations: Falsely marketing products with 1% hydrocortisone as “maximum strength”
ACT Dry Mouth Lozenges
Case Name (Date)
Tlaib et al. v. Chattem, Inc.
23-cv-376, N.D. Ill.
(Jan. 2023)
Product/Service
ACT Dry Mouth Lozenges
Allegations
Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin, which contributes to demineralization, dental erosion, and sensitivity
Status
Pending
Class-Action Tracker
Cortizone-10 Products
Allegations: Misleadingly marketing products as “Maximum Strength”
Unisom Simple Slumbers
Allegations: False natural claims
Dulcolax
Allegations: False natural claims
ACT Total Care Anticavity Fluoride Mouthwash
ACT Restoring Mouthwash
ACT® Restoring™ Anticavity Fluoride Mouthwash
The Latest
Aspercreme
TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.
ACT Dry Mouth Mouthwash, Lozenges
NAD tells marketer to watch its mouth when it comes to making certain dry mouth product claims.
Nasacort
Makers of nasal allergy spray told to cease consumer preference claims.